Could a cure for Alzheimer's be closer than we think? ONE BioHub tenants explore the future of brain health
A compelling new episode of the Pulse podcast brings together two ONE BioHub tenants for a wide-ranging conversation about one of medicine's greatest challenges and why there may be more reason for optimism than many realise.
The episode features Aldo De Pape, CEO of Genomes.io, in conversation with Professor Craig Ritchie, founder and CEO of Scottish Brain Sciences, covering some of the most pressing and exciting topics at the frontier of neuroscience and healthcare innovation. From Alzheimer's disease and brain health, to entrepreneurship, artificial intelligence, and genetics, the discussion ranges across the ideas and breakthroughs that are shaping the future of how we understand and treat brain conditions.
Central to the conversation is Professor Ritchie's belief that a cure for Alzheimer's may be closer than the wider public appreciates, a perspective grounded in his extensive research and experience at the leading edge of brain health science. It is a vision that is both ambitious and, he argues, increasingly within reach.
The episode is as much about thinking bigger as it is about the science itself, exploring what it takes to turn bold ideas into real-world impact, and how entrepreneurship and innovation are driving progress in healthcare. With both De Pape and Ritchie working at the intersection of genomics, data, and neuroscience, the conversation reflects the kind of cross-disciplinary collaboration that ONE BioHub was built to foster.